Broker says Pilbara Minerals share price is heading even higher

Recent share price weakness could be a buying opportunity for investors…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pilbara Minerals Ltd (ASX: PLS) share price is back on form on Thursday.

In afternoon trade, the lithium miner's shares are up 4.5% to $4.45.

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.

Image source: Getty Images

Why is the Pilbara Minerals share price rising?

Today's gain by the Pilbara Minerals share price comes despite there being no news out of the company.

However, with its shares down meaningfully this month, some investors appear to have been buying them on the belief that they have been oversold.

One leading broker that would support this buying is Canaccord Genuity. Earlier this week, the broker reiterated its buy rating with a $5.00 price target.

Even after today's gain, this price target implies potential upside of 12% for investors over the next 12 months.

What did the broker say?

Canaccord Genuity notes that the company has announced a new sales arrangement for a 15,000 tonne cargo of spodumene concentrate.

This agreement has been structured to be based on a tolling arrangement under which Pilbara Minerals will receive the value of the lithium hydroxide price for the product sold, less an agreed amount for conversion and other costs.

Canaccord Genuity believes this is a great move by management and expects it to result in a price comfortably ahead of its estimates.

This bodes well for its near term earnings and may mean recent panic selling has been an overreaction. It commented:

With spot LiOH [lithium hydroxide] pricing of ~US$65,000/t this implies a tolling and cost "charge" of US$6,000/t to achieve ~US$8.200/t. If we were to use the Wuxi carbonate futures as an indication to April 2023 pricing (US$45,803/t) this would result in an approximate realised price of US$5,528/t at time of conversion. This calculation doesn't factor for the ~US$7,000/t premium for lithium hydroxide over carbonate (potentially an incremental ~US$1.000/t on pricing). Either way. the estimated read-through is well north of our US$4,500/t MarQ'23 assumption and US$3,500/t JunQ'23 assumption.

The broker concludes:

Based on the current stock price, our model indicates the equity market is pricing PLS at US$1,575/t SC6 flat into the future. Near-term earnings would be impacted (at US$1,575/t); however, we would still see value given our US$1,500/t LT assumption. Conversely, if spot prices were to hold until the end of FY23, its cash balance could grow to AS3.5bn (from As2.2bn at the end of DecO'22) and we estimate there could be ~22% upside to FY23 EBITDA (+149% if held through FY24).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »